JPS61210036A - Sulfur-compounded external drug for skin - Google Patents

Sulfur-compounded external drug for skin

Info

Publication number
JPS61210036A
JPS61210036A JP5194685A JP5194685A JPS61210036A JP S61210036 A JPS61210036 A JP S61210036A JP 5194685 A JP5194685 A JP 5194685A JP 5194685 A JP5194685 A JP 5194685A JP S61210036 A JPS61210036 A JP S61210036A
Authority
JP
Japan
Prior art keywords
sulfur
drug
skin
external
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5194685A
Other languages
Japanese (ja)
Inventor
Takeshi Yanagida
威 柳田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP5194685A priority Critical patent/JPS61210036A/en
Publication of JPS61210036A publication Critical patent/JPS61210036A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0275Containing agglomerated particulates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88Polyamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12Face or body powders for grooming, adorning or absorbing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/622Coated by organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/624Coated by macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)

Abstract

PURPOSE:To provide a sulfur-compounded external drug for skin, obtained by compounding insoluble polymer powder together with sulfur to an external drug, preventing the coagulation of sulfur during the production or storage of the drug, giving improved stability to the drug compounded with the agent, and useful for the prevention and remedy of pimple and the reducive bleaching of the skin. CONSTITUTION:A sulfur-containing external drug for skin having improved stability can be produced by adding polymer powder insoluble in the base of an external dermatic drug (e.g. polyethylene, polyvinyl chloride, crystalline cellulose powder, etc.) together with sulfur to the dermatic drug base. The amount of the polymer powder is preferably >=1/2 of sulfur. The external dermatic drug base to be compounded with the insoluble polymer powder in combination with sulfur is e.g. cleansing agent, remedy for pimple, skin-beautifying cosmetic, etc., and conventional generations or creamy base, etc., can be used. An external dermatic drug having extremely high quality and free from coagulation of sulfur can be produced by this process.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は硫黄とともに皮膚外用剤基剤に不溶の粉末を配
合することにより、その配合製剤の安定性を向上させた
皮膚外用剤に関するものである。
[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to a skin external preparation that improves the stability of the combined preparation by incorporating an insoluble powder into the skin external preparation base together with sulfur. be.

[従来の技術] 従来硫黄はに営びの予防、治療の目的で軟膏、クリーム
、洗顔料などに用いられたり、還元漂白を目的として多
くの皮膚外用剤に用いられている。
[Prior Art] Sulfur has conventionally been used in ointments, creams, facial cleansers, etc. for the purpose of preventing and treating acne scarring, and has been used in many external skin preparations for the purpose of reductive bleaching.

しかしながら硫黄は皮膚外用剤中で、製造中あるいは保
存中に凝集し、均一分散ができないばかりか凝集物は沈
降を加速し、品質の劣化を増長するものであった。
However, sulfur aggregates in skin preparations during manufacturing or storage, making it impossible to disperse uniformly, and the aggregates accelerate sedimentation, increasing deterioration of quality.

[発明が解決しようとしている問題点]本発明者らは係
る事情に鑑み鋭意研究の結果、皮膚外用剤の処方中に硫
黄とともに不溶性高分子粉末を配合すれば製造中はもち
ろん保存中ざえも硫黄の凝集が防止できることを見出し
本発明を完成するに至った。
[Problems to be solved by the invention] In view of the above-mentioned circumstances, the present inventors have conducted intensive research and found that if insoluble polymer powder is combined with sulfur in the formulation of external skin preparations, sulfur will be released not only during manufacturing but also during storage. The present invention was completed based on the discovery that the aggregation of .

[問題点を解決するための手段および作用]すなわち、
本発明は硫黄とともに皮膚外用剤基剤に不溶の粉末を配
合することにより、その配合製剤の安定性を向上させた
ことを特徴とする皮膚外用剤である。
[Means and actions for solving the problem] That is,
The present invention is a skin external preparation characterized by incorporating an insoluble powder into the skin external preparation base together with sulfur, thereby improving the stability of the combined preparation.

本発明で用いられる硫黄は通常皮膚外用剤用として供給
されているものでかまわなく、その配合量としては任意
であり、期待する効果の程度によって決定される。しか
し極端に硫黄の配合量が多い場合には皮膚外用剤基剤の
分量が少なくなり、皮膚外用剤基剤自身の性能を発揮出
来なくなる場合がある。好ましくは0.1〜10%であ
る。
The sulfur used in the present invention may be one that is normally supplied for external use on the skin, and the amount of sulfur to be added is arbitrary and determined depending on the expected degree of effect. However, if the amount of sulfur blended is extremely large, the amount of the skin external preparation base will be reduced, and the skin external preparation base may not be able to exhibit its own performance. Preferably it is 0.1 to 10%.

また本発明において硫黄とともに皮膚外用剤に配合きれ
る不溶性高分子粉末としては水性皮膚外層剤基剤に°配
合きれるものとしてはポリエチレン、ポリプロピレン、
ポリスチレン、ポリスチレンジビニルベンゼン共重合体
などの炭化水素系の高分子、塩化ビニル、塩化ビニリデ
ン、弗化エチレンなどのハロゲン化炭化水素系の高分子
、ナイロンなどのポリアミド系高分子、アクリロニトリ
ル、メチルメタアクリレートなどのアクリル系高分子や
、フェノール系高分子、ポリエステル系高分子、などの
汎用合成高分子材料の粉末、あるいは結晶性セルロース
パウダーのような天然物由来の高分子粉末などが利用で
きる。
In addition, in the present invention, insoluble polymer powders that can be incorporated into external skin preparations together with sulfur include polyethylene, polypropylene,
Hydrocarbon polymers such as polystyrene and polystyrene divinylbenzene copolymers, halogenated hydrocarbon polymers such as vinyl chloride, vinylidene chloride, and ethylene fluoride, polyamide polymers such as nylon, acrylonitrile, and methyl methacrylate. Powders of general-purpose synthetic polymer materials such as acrylic polymers such as phenol polymers and polyester polymers, and polymer powders derived from natural products such as crystalline cellulose powder can be used.

いずれの場合も本発明の効果を期待して配合する粉末は
配合する皮膚外用剤基剤に不溶のものを用いないと本発
明の効果は発揮されない。
In any case, the effects of the present invention will not be exhibited unless the powder blended with the expectation of the effects of the present invention is insoluble in the base of the external skin preparation.

また油性の皮膚外用剤基剤中に配合される粉末としては
前述の高分子粉末のうち皮膚外用剤基剤との溶解性を考
慮すればそのほとんどがもちいれる。ざらに油性基剤の
場合にはショ糖、乳糖、糖アルコールなどの糖粉束も用
いることができる。
Also, as the powder to be incorporated into the oil-based skin external preparation base, most of the above-mentioned polymer powders can be used in consideration of their solubility with the skin external preparation base. In the case of coarsely oily bases, powdered sugars such as sucrose, lactose, and sugar alcohols can also be used.

以上に述べた高分子粉末を一種または二種以上を用いる
が、その高分子粉末を配合する量としては同時に皮膚外
用剤に配合きれる硫黄の量とを考え合わせて決定される
。本発明の効果を発揮する量としては硫黄量の1/2以
上がのぞましい。また硫黄の量より極端に多い高分子粉
末を配合した場合、本発明の効果が減少するものではな
いが、前述の硫黄の場合と同様に皮膚外用剤基剤の分量
が減少し皮膚外用剤白層の性能を阻害することとなる。
One or more of the above-mentioned polymer powders are used, and the amount of the polymer powder to be blended is determined by taking into consideration the amount of sulfur that can be blended into the external skin preparation. The amount to exhibit the effects of the present invention is preferably 1/2 or more of the amount of sulfur. Furthermore, if a polymer powder that is extremely larger than the amount of sulfur is blended, the effect of the present invention will not be reduced, but as in the case of sulfur, the amount of the skin external preparation base will decrease and the skin external preparation will become whiter. This will impede the performance of the layer.

本発明にしたがって硫黄と不溶性高分子粉末を配合され
る皮膚外用剤基剤としては、洗浄料をはじめニキビ治療
薬、美白化粧料などのもので、ゲル状、クリーム状など
の通常の皮膚外用剤基剤が利用できる。また製造時に溶
解状態で製造する固形石鹸にも応用できる。
The base for external skin preparations containing sulfur and insoluble polymer powder according to the present invention includes detergents, anti-acne drugs, whitening cosmetics, etc., and is commonly used in gel-like, cream-like, etc. Bases are available. It can also be applied to solid soaps that are manufactured in a dissolved state during manufacturing.

本発明による手法で硫黄とともに不溶性高分子粉末を皮
膚外用剤に配合した場合、硫黄の凝集がなく非常に品質
のよい皮膚外用剤が得られたが、それに比較して硫黄の
みを配合したものは、皮膚外用剤 中で硫黄が凝集、沈降し著しい品質の劣化をおこした。
When an insoluble polymer powder was blended with sulfur into a skin external preparation using the method of the present invention, a skin external preparation with very good quality without sulfur aggregation was obtained. , sulfur coagulated and precipitated in the external skin preparation, causing a significant deterioration in quality.

[実施列] つぎに本発明を実施例および比較例によりざら° に詳
細に説明するが本発明はこれにより限定されるものでは
ない。
[Example Series] Next, the present invention will be explained in detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto.

〈実施例1〉 ラウロイルグルタミン11     25 w t%ナ
トリウム ヤシ油ジェタノールアマイド    5PEG1500
         15グリセリン         
  25グリセリルモノステアレート    2精製水
         全体を100とする量香料    
           適量粉末硫黄        
     1ポリエチレン粉末         3硫
黄およびポリエチレンを除く成分を70’Cで加熱溶解
したのち、硫黄およびポリエチレンを仕込む。分散機に
より硫黄とポリエチレン粉末を均一に分散せしめ、その
のち冷却処理をおこない硫黄を安定に配合した洗浄料を
得る。
<Example 1> Lauroyl glutamine 11 25 wt% sodium coconut oil jetanolamide 5PEG1500
15 Glycerin
25 Glyceryl monostearate 2 Purified water Amount to make the total 100 Fragrance
Appropriate amount of powdered sulfur
1. Polyethylene powder 3. After heating and melting all components except sulfur and polyethylene at 70'C, sulfur and polyethylene are charged. Sulfur and polyethylene powder are uniformly dispersed using a dispersing machine, and then a cooling process is performed to obtain a cleaning agent that stably contains sulfur.

く比較例1〉 実施例1の処方よりポリエチレン粉末を除いたもので、
硫黄以外の成分を70’Cで加熱溶解したのち硫黄を仕
込み、実施例1と同じ条件で分散処理、冷却処理したも
の。
Comparative Example 1> The formulation of Example 1 except that the polyethylene powder was removed,
Components other than sulfur were heated and dissolved at 70'C, then sulfur was added, followed by dispersion treatment and cooling treatment under the same conditions as in Example 1.

実施例1および比較例1の洗顔料を分散処理直後(製造
釜内)、および冷却処理の開始直後、途中3個所、終了
直前の各ポイント(冷却機出口)でサンプリングし、試
料中の硫黄含有量を測定した。
The facial cleansers of Example 1 and Comparative Example 1 were sampled immediately after the dispersion treatment (inside the production kettle), immediately after the start of the cooling treatment, at three points during the cooling treatment, and at each point just before the end (at the outlet of the cooling machine) to determine the sulfur content in the samples. The amount was measured.

表−1 表−1よりもあきらかなように硫黄のみを配合した比較
例1においては分散処理直後は硫黄が均一に分散してい
るものの、冷却処理に至るまでの時間に凝集がおこり、
その凝集物が早い速度で沈降するため、皮膚外用剤とし
ては硫黄の量が一定しない品質の悪いものである。
Table 1 As is clearer from Table 1, in Comparative Example 1 in which only sulfur was blended, sulfur was uniformly dispersed immediately after the dispersion treatment, but agglomeration occurred during the time leading up to the cooling treatment.
Since the aggregates settle out at a high rate, it is of poor quality as an external preparation for the skin because the amount of sulfur is not constant.

これ゛に比べ実施例1では本発明にしたがって硫黄とと
もに不溶性高分子粉末(本例ではポリエチレン粉末)を
配合しであるため、分散処理直後の製造釜内ではもちろ
ん時間がたって冷却処理に移りざらには冷却処理終了ま
で硫黄量の一定した非常に優れた皮膚外用剤が得られる
In contrast, in Example 1, in accordance with the present invention, insoluble polymer powder (polyethylene powder in this example) was blended with sulfur, so that it could not only be carried out in the production kettle immediately after dispersion treatment but also not transferred to cooling treatment over time. An extremely excellent skin preparation with a constant sulfur content until the end of the cooling process can be obtained.

これは本発明に係る効果である。This is an effect related to the present invention.

〈実施例2〉 アシルグルタミン酸      83.4vtXモノナ
トリウム (WJ品名アミソフトG5−11) セタノール           5.0精製水   
          9.○酸化チタン       
     0.1香料              適
量粉末硫黄            2.0ナイロンパ
ウダー        0.5硫黄およびナイロンパウ
ダー以外の成分を7000で加熱溶解したのち50°C
まで冷却する。
<Example 2> Acylglutamic acid 83.4vtX monosodium (WJ product name Amisoft G5-11) Setanol 5.0 Purified water
9. ○Titanium oxide
0.1 Fragrance Appropriate amount Powdered sulfur 2.0 Nylon powder 0.5 Heat and melt the ingredients other than sulfur and nylon powder at 7000°C, then 50°C
Cool until cool.

そののち硫黄およびナイロンパウダーを分散処理し、つ
いで室温まで冷却する。ざらにブレンダーにより練合し
て硫黄を安定に配合した固形石鹸を得る。
Thereafter, sulfur and nylon powder are dispersed and then cooled to room temperature. Roughly knead with a blender to obtain a solid soap containing stably blended sulfur.

〈実施例3〉 A、精製水       全体を100とする量グリセ
リン          10wt%苛性カリ    
          0.283セタノール     
       4ステアリン酸           
2.5ワセリン             8流動パラ
フイン         10グリセリルモノステアレ
ート    3イソプロピルミリステート     5
エチルパラベン          0.2香料   
           適量C0粉末硫黄      
       0.5セルロースパウダー      
  5Aの成分、Bの成分をそれぞれ70’Cにて加熱
溶解したのちAのなかへBを加え乳化する。モののちC
の硫黄およびセルロースパウダーを加え、分散処理した
のち冷却処理をおこない、硫黄を安定に配合した皮膚外
用剤を得る。
<Example 3> A. Purified water Amount to make the whole 100 Glycerin 10wt% Caustic potassium
0.283 cetanol
4 stearic acid
2.5 Vaseline 8 Liquid paraffin 10 Glyceryl monostearate 3 Isopropyl myristate 5
Ethylparaben 0.2 fragrance
Appropriate amount of C0 powder sulfur
0.5 cellulose powder
Component 5A and component B are respectively heated and dissolved at 70'C, and then B is added to A and emulsified. Monochi C
Add sulfur and cellulose powder, perform a dispersion treatment, and then perform a cooling treatment to obtain a skin preparation with a stable blend of sulfur.

〈実施例4〉 A、精製水       全体を100とする量エチル
アルコール       5.○wtχプロピレングリ
コール    10.○カルボキシビニルポリマー  
 0.8B、粉末硫黄           5.○ポ
リプロピレンパウダー    5.OC0苛性カリ  
          0.2Aの成分を室温で溶解した
のちBの粉末硫黄およびポリプロピレンパウダーを添加
する。分散処理を施した後、Cのアルカリを加えて中和
し、硫黄を安定に配合したゲル状皮膚外用剤を得る。
<Example 4> A. Purified water Ethyl alcohol in an amount with the total as 100 5. ○wtχ Propylene glycol 10. ○Carboxyvinyl polymer
0.8B, powdered sulfur 5. ○Polypropylene powder 5. OC0 caustic potash
After 0.2 components A are dissolved at room temperature, powdered sulfur and polypropylene powder B are added. After the dispersion treatment, an alkali (C) is added to neutralize the mixture to obtain a gel-like skin preparation stably containing sulfur.

〈実施例5〉 A、ワセリン           40wt%固形パ
ラフィン        2 ピースワツクス        2 POE (20)セチルエーテル     2ステアリ
ン酸         2 シリコンオイル        2 スクワラン         35 香料            適量 B、粉末硫黄          10粉末乳I!3 ナイロンパウダー       2   。
<Example 5> A, Vaseline 40wt% solid paraffin 2 Piece wax 2 POE (20) Cetyl ether 2 Stearic acid 2 Silicone oil 2 Squalane 35 Fragrance Appropriate amount B, Powdered sulfur 10 Powdered milk I! 3. Nylon powder 2.

Aの成分を75°Cで溶解したのも55°Cまで冷却す
る。そののちBの硫黄、乳糖、ナイロンパウダーを添加
し分散処理する。ついで冷却処理を行い、硫黄を安定に
配合した軟膏状皮膚外用剤を得る。
The component A dissolved at 75°C is also cooled to 55°C. After that, sulfur, lactose, and nylon powder (B) are added and dispersed. Then, a cooling treatment is performed to obtain an ointment-like external preparation for skin containing a stable combination of sulfur.

Claims (1)

【特許請求の範囲】[Claims] 硫黄とともに不溶性高分子粉末を配合したことを特徴と
する皮膚外用剤
A topical skin preparation that is characterized by containing sulfur and insoluble polymer powder.
JP5194685A 1985-03-15 1985-03-15 Sulfur-compounded external drug for skin Pending JPS61210036A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5194685A JPS61210036A (en) 1985-03-15 1985-03-15 Sulfur-compounded external drug for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5194685A JPS61210036A (en) 1985-03-15 1985-03-15 Sulfur-compounded external drug for skin

Publications (1)

Publication Number Publication Date
JPS61210036A true JPS61210036A (en) 1986-09-18

Family

ID=12901037

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5194685A Pending JPS61210036A (en) 1985-03-15 1985-03-15 Sulfur-compounded external drug for skin

Country Status (1)

Country Link
JP (1) JPS61210036A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249714A (en) * 1988-08-12 1990-02-20 Shiseido Co Ltd Cosmetic
JPH032124A (en) * 1989-05-30 1991-01-08 Terumo Corp Liquid agent for external application
JPH11228346A (en) * 1998-02-12 1999-08-24 Kose Corp Cosmetic

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49126583A (en) * 1973-04-09 1974-12-04
JPS5083268A (en) * 1973-11-29 1975-07-05
JPS53145906A (en) * 1977-05-25 1978-12-19 Yamanouchi Pharmaceut Co Ltd Stable aqueous dispersion of 10-propionyl gosamycin
JPS5446820A (en) * 1977-08-18 1979-04-13 Upjohn Co Pharmaceutical liquid suspending agent composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49126583A (en) * 1973-04-09 1974-12-04
JPS5083268A (en) * 1973-11-29 1975-07-05
JPS53145906A (en) * 1977-05-25 1978-12-19 Yamanouchi Pharmaceut Co Ltd Stable aqueous dispersion of 10-propionyl gosamycin
JPS5446820A (en) * 1977-08-18 1979-04-13 Upjohn Co Pharmaceutical liquid suspending agent composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249714A (en) * 1988-08-12 1990-02-20 Shiseido Co Ltd Cosmetic
JPH032124A (en) * 1989-05-30 1991-01-08 Terumo Corp Liquid agent for external application
JPH11228346A (en) * 1998-02-12 1999-08-24 Kose Corp Cosmetic

Similar Documents

Publication Publication Date Title
JP3658451B2 (en) Benzoyl peroxide composition
US5952395A (en) Gelled ultrafine oil-in-water emulsion stabilized with a crosslinked poly(2-acrylamido-2-methylpropanesulfonic acid) polymer neutralized to at least 90% process of preparation and applications
JPH08225465A (en) Composition in the form of dispersion and process for its preparation
JPH10212226A (en) Topical composition containing at least one protein of plant origin and / or at least one protein of animal origin and at least one cross-linked poly (2-acrylamido-2-methylpropanesulfonic acid)
CA2174031C (en) Benzoyl peroxide compositions
JP2000256188A (en) Emulsifier composition
CA1142854A (en) Method and compositions for the treatment of seborrhea
JP2000290135A (en) Agent for promoting restoration of skin barrier function
JPS61210036A (en) Sulfur-compounded external drug for skin
JPH06157237A (en) Humectant and cosmetic, skin external agent containing the same
CN1252990A (en) Vitamin A stable cleaning composition
JPH07100357A (en) Emulsified composition
JP4052546B2 (en) Skin preparation
JPH0381400A (en) Detergent composition
JPS6093B2 (en) Method for producing oil-based gel
JPS6092399A (en) Cream emulsion cleaning agent
JP2003104826A (en) W/o/w composite emulsion
JP3596636B2 (en) Detergent composition
JP3213868B2 (en) Pack cosmetics
JPH0374313A (en) Composition for external use
JP2003104836A (en) W/o/w type emulsion
GB1575201A (en) Method of lubricating or softening the skin
JP4456778B2 (en) Gel composition and external preparation for skin comprising the same
JPS62195316A (en) Dermatic drug
JP3462332B2 (en) Oil gelling agent and cosmetic containing the same